Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Joey Porrello Presented with Jenifer Estess Award
“None of us would be here without Jenifer Estess. Yes, sure, there are countless other factors that brought us together today. Personally, having ALS jumps
June 1, 2023
No Comments
